arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 11/2013 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    At the second attempt: varicella-zoster vaccine ZOSTAVAX

    Alemtuzumab (LEMTRADA) for multiple sclerosis

    Atomoxetine (STRATTERA) for adults with attention deficit hyperactivity disorder (ADHD)?

    a-t READERS' QUESTIONS AND COMMENTS

    Intramuscular injection of vaccines in patients receiving anticoagulation therapy?

    Ciclesonide (ALVESCO) against asthma

    WOBENZYM PLUS/PHLOGENZYM for osteoarthritis and others

    IN BRIEF

    Teva/Ratiopharm - advertisement for sildenafil generics at the lowest niveau

    CURRENT ADR NETWORK REPORT

    Tinnitus with proton pump inhibitors
    free

    SIDE EFFECTS

    EMA: frequency of thromboembolism with contraceptives reassessed

    Lethal liver damage due to agomelatine (VALDOXAN)

    e a-t IN INTERNET

    One in three to four clinical trials remain unpublished

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles